I'm not really all that mysterious

Shkreli at It Again

Shkreli, the CEO of Turing Pharmaceuticals who jacked up the price of Daraprim (pyrimethamine), wants to do the same thing to benznidazole, one of two medications known to be effective in treating Chagas disease.

Currently it costs $60-$100 per treatment course, but he wants to increase it to $80k-$100k per treatment course.

I guess it’s time to invest in whoever makes nifurtimox (the other medication known to be effective in treating Chagas disease.)

Pharma Bro’s Latest Move Targets Latinos • 2015 Dec 15 • Daisy Hernandez • Bernie Sanders

Martin Shkreli plans to raise price of drug for parasitic infection Chagas disease • 2015 Dec 15 • Laura Bult • NY Daily News

initially published online on:
page regenerated on: